Publications by authors named "Lobna M Anees"

Background And Objective: Cisplatin, an effective drug against cancer, commonly induces nephrotoxicity; limiting its therapeutic efficacy and application. In this study, Cisplatin NanoComposite (Cis NC) was formulated successfully from irradiated chitosan coated Cisplatin and MgO nanoparticles (CHIT/Cis/MgO NPs) to promote cisplatin release in a more sustained manner to improve therapeutic efficacy via the reduction of its nephrotoxicity. To compare the relative induced renal toxicity of cisplatin with Cisplatin NanoComposite, histological and biochemical mechanisms underlying nephrotoxicity were investigated.

View Article and Find Full Text PDF

Despite their clinical benefits in cancer treatment, the deleterious effects on heart following chemo/radiotherapy are of increasing importance. Zingerone, a natural polyphenol, possesses multiple biological activities, such as antioxidant and anti-inflammatory. Thus, the current study was designed to assess the potential cardioprotective effects of zingerone against cisplatin or γ-radiation.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Lobna M Anees"

  • - Lobna M Anees focuses on developing innovative nano-based formulations, such as Cisplatin NanoComposite (Cis NC), to mitigate the nephrotoxic effects associated with cisplatin chemotherapy.
  • - The research demonstrates that the formulated Cis NC enhances the sustained release of cisplatin while significantly reducing renal toxicity, thereby potentially improving the drug's therapeutic efficacy in cancer treatment.
  • - Additionally, Anees investigates the cardioprotective properties of natural compounds like zingerone against oxidative stress and inflammation induced by cisplatin or gamma radiation, highlighting alternative strategies to protect against chemotherapy-induced cardiac damage.